参考文献

[1]王临虹，赵更力.子宫颈癌综合防控指南（第2版）[M].北京：人民卫生出版社，2023.

[2]World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem[M]. Geneva:World Health Organization,2020.

[3]Wang L. Accelerating cervical cancer prevention and control in China to achieve cervical cancer elimination strategy objectives[J]. China CDC Wkly,2022,4(48):1067-1069.

[4]健康中国行动推进委员会.健康中国行动（2019—2030年）[EB/OL].(2019-07-09)[2024-01-10]. https://www.gov.cn/xinwen/2019-07/15/content_5409694.htm.

[5]中华人民共和国国务院.国务院关于印发中国妇女发展纲要和中国儿童发展纲要的通知[EB/OL].(2021-09-08)[2024-01-10]. https://www.gov.cn/zhengce/content/2021-09/27/content_5639412.htm.

[6]国家卫生健康委员会，中华人民共和国教育部，中华人民共和国民政部，等.关于印发加速消除宫颈癌行动计划（2023—2030年）的通知[EB/OL].(2023-01-05)[2024-01-10]. https://www.gov.cn/zhengce/zhengce ku/2023-01/21/content_5738364.htm.

[7] World Health Organization. Human papillomavirus vaccines:WHO position paper(2022 update)[J]. Weekly Epidemiological Record,2022,97(50):645-672.

[8]World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention[M]. 2nd ed. Geneva:World Health Organization,2021.

[9] World Health Organization. WHO framework for strengthening and scaling-up services for the management of invasive cervical cancer[M]. Geneva:World Health Organization,2020.

[10]中国优生科学协会阴道镜和宫颈病理学分会专家委员会.中国子宫颈癌筛查及异常管理相关问题专家共识（一）[J].中国妇产科临床杂志，2017,18(2):190-192.

[11]中国优生科学协会阴道镜和宫颈病理学分会（CSCCP）专家委员会.中国子宫颈癌筛查及异常管理相关问题专家共识（二）[J].中国妇产科临床杂志，2017,18(3):286-288.

[12]魏丽惠，赵昀，谢幸，等.妊娠合并子宫颈癌管理的专家共识[J].中国妇产科临床杂志，2018,19(2):190-192.

[13]中华预防医学会疫苗与免疫分会.子宫颈癌等人乳头瘤病毒相关疾病免疫预防专家共识[J].中华预防医学杂志，2019,53(8):761-803.

[14]中华医学会妇科肿瘤学分会，中国优生科学协会阴道镜和宫颈病理学分会.人乳头瘤病毒疫苗临床应用中国专家共识[J].中国妇产科临床杂志，2021,22(2):225-234.

[15]毕蕙，李明珠，赵超，等.子宫颈低级别鳞状上皮内病变管理的中国专家共识[J].中国妇产科临床杂志，2022,23(4):443-445.

[16]赵超，毕蕙，赵昀，等.子宫颈高级别上皮内病变管理的中国专家共识[J].中国妇产科临床杂志，2022,23(2):220-224.

[17] American Society for Colposcopy and Cervical Pathology. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors[J]. J Low Genit Tract Dis,2017,21(4):216-222.

[18]WHO Classification of Tumours Editorial Board. WHO classification of tumours. Female genital tumours[M].5th ed. Lyon:IARC Press,2020.

[19] Bhatla N, Berek JS, Fredes MC, et al. Revised FIGO stagingfor carcinoma of the cervix uteri[J]. Int J Gynecol Obstet,2019,145(1):129-135.